Tolerance to a New Free Amino Acid-based Formula in Children With IgE or Non-IgE-mediated Cow's M… (NCT01622426) | Clinical Trial Compass
CompletedNot Applicable
Tolerance to a New Free Amino Acid-based Formula in Children With IgE or Non-IgE-mediated Cow's Milk Allergy
Italy60 participantsStarted 2008-10
Plain-language summary
The investigators aim to assess the tolerance to a new commercially available Aaf in children affected by IgE- or non-IgE-mediated CMA.
Who can participate
Age range1 Month – 168 Months
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Pediatric patients (≤14 years of age) with a recent diagnosis of IgE- or non-IgE-mediated CMA, confirmed by positive DBPCFC or anaphylaxis in the 2 months prior to enrollment and under good clinical control.
Exclusion Criteria:
* Children with concomitant chronic systemic diseases
* Congenital cardiac defects
* Active tuberculosis
* Autoimmune diseases
* Immunodeficiency
* Chronic inflammatory bowel diseases
* Celiac disease
* Cystic fibrosis
* Metabolic diseases
* Lactose intolerance
* Malignancy
* Chronic pulmonary diseases
* Malformations of the gastrointestinal tract
* Gastroesophageal reflux disease non-food allergy-related
* Suspected eosinophilic gastrointestinal disorders, were excluded.
What they're measuring
1
Tolerance to a new free amino acid-based formula in children with IgE or non-IgE-mediated cow's milk allergy